Evidence-Based Medicine Guidelines
Risperidone versus olanzapine for schizophrenia
Risperidone versus olanzapine for schizophrenia is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Risperidone Versus Olanzapine for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452881/all/Risperidone_versus_olanzapine_for_schizophrenia.
Risperidone versus olanzapine for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452881/all/Risperidone_versus_olanzapine_for_schizophrenia. Accessed March 1, 2021.
Risperidone versus olanzapine for schizophrenia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452881/all/Risperidone_versus_olanzapine_for_schizophrenia
Risperidone Versus Olanzapine for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2021 March 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452881/all/Risperidone_versus_olanzapine_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risperidone versus olanzapine for schizophrenia
ID - 452881
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452881/all/Risperidone_versus_olanzapine_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
